Navigation Links
High rate of complicated idiopathic gallstone disease in pediatric patients
Date:4/30/2008

The prevalence of gallstones in adults of industrialized countries is approximately 10% and is showing a tendency to rise. Data for pediatric patients is scarce.

A research article published on March 14, 2008, in the World Journal of Gastroenterology addresses this problem. The team lead by Dr. Denise Herzog from Sainte Justine Hospital, University of Montreal, Canada, has reviewed the rate of gallstone disease and its mode of presentation in pediatric patients requiring abdominal ultrasound at Sainte Justine Hospital between 2003 and 2005.

According to their results, idiopathic gallstone disease and complicated disease presentation were much more frequent than expected from previous studies, and it presented as complicated disease in 58% of patients, especially in adolescent girls.

The authors recommend that pediatricians become more aware of this disease, which until now was associated with adult patients only. In the light of the recent detection of the human Lith gene ABCG5/G8 and its association with the risk of cholesterol gallstone formation, the value of genetic evaluations of such families in order to prevent complicated disease presentation should be discussed. Further epidemiological data is required to decide whether genetic screening of families will help to prevent complicated disease presentation.


'/>"/>

Contact: Jing Zhu
wjg@wjgnet.com
0086-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1

Related medicine news :

1. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
2. MultiVu Video Feed: FDA Approves DORIBAX(TM) (doripenem for injection) for the Treatment of Complicated Intra-abdominal and Complicated Urinary Tract Infections
3. MIT: Stem-cell therapies for brain more complicated than thought
4. Depression in the Elderly is Complicated but Treatable, From the Harvard Mental Health Letter
5. Flip-chart book translates complicated medical procedures into easy-to-understand language
6. Admission-Day Crowding May Increase Hospital Stay for Children With Less Complicated Illnesses
7. Eltrombopag studied in Idiopathic Thrombocytopenic Purpura
8. Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis
9. Exclusion of common bile duct stones prior to gallstone operations
10. Early surgical treatment contributes to better outcomes in gallstone pancreatitis cases
11. U of I study: exercise to avoid gallstones!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... the only authorized OSHA Training Institute Education Center headquartered in Northern California, has ... workers from extreme heat at their worksites. Employers with workers exposed to ...
(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/27/2016)... (PRWEB) , ... June 27, ... ... in the patient payment industry today announced its strategic partnership with Connance, ... system workflows. , The two companies’ proven, proprietary technology combine to provide ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... cutting edge technology to revolutionize the emergency ambulance transport experience for the millions ... aware of how Uber has disrupted the taxi industry through the use of ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals plc ... period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, ... of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ... (Eastern Daylight Time). As previously announced on ... a definitive merger agreement under which Jazz Pharmaceuticals has ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: